Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...

Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

With the rise in the popularity of weight loss drugs like ‘Wegovy’ and ‘Ozempic,’ we’re learning a counterfeit market has ...

According to Novo Nordisk’s website, the price of an Ozempic pen (0.25 or 0.5 mg) is $968.52 ... two innovators are ...

One shipment of suspected counterfeit Wegovy was hidden inside a Mickey Mouse puzzle for ... Novo Nordisk reported one counterfeit pen contained the diabetes medicine insulin. The user was ...

It is thought to be the first death in the UK linked to the medication Mounjaro, nicknamed the ‘King Kong jab’ ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...